Zydus Lifesciences receives USFDA approval to market Azilsartan Medoxomil and Chlorthalidone tablets for high blood pressure treatment.

Zydus Lifesciences has received USFDA approval to market Theophylline extended-release tablets for asthma and COPD. The drug will be manufactured in Ahmedabad SEZ.

Zydus Lifesciences receives USFDA approval for its generic Theophylline extended-release tablets for treating asthma and COPD. The drug will be manufactured in Ahmedabad.

Zydus Lifesciences' net profit for the fourth quarter ended March 31, 2024, jumped four-fold to Rs 1,182 crore on higher sales. Revenue also rose to Rs 5,534 crore.

Zydus Lifesciences has partnered with MSN Laboratories to bring a generic version of the cancer drug Cabozantinib to the US market, aiming to provide affordable treatment options.

India's food services market is projected to reach Rs 10 lakh crore by 2030, driven by online delivery growth and rising consumer spending.

S&P Global Ratings says India's sovereign rating could be upgraded within 24 months if the government brings down fiscal deficit to 4% of GDP. The agency expects India's economy to grow at 6.8% in...

Mahindra Group Chairman Anand Mahindra urges Indian companies to increase capital investment to capitalize on growth opportunities in India and globally. He emphasizes the need for a shift in...

India's tyre industry is facing a severe shortage of natural rubber, which could disrupt production. The Automotive Tyre Manufacturers' Association (ATMA) is urging the government to address the...

Franklin Templeton predicts slower equity returns over the next three years, citing high valuations and a shift in earnings growth. Despite this, they expect respectable returns compared to other...

CBIC Chairman reveals GST Council decisions on amnesty, profiteering, and rate rationalization will be incorporated into the Finance Bill 2024. Learn about the key amendments and their implications.

India's food services market is projected to reach Rs 10 lakh crore by 2030, driven by online delivery growth and rising consumer spending.

S&P Global Ratings says India's sovereign rating could be upgraded within 24 months if the government brings down fiscal deficit to 4% of GDP. The agency expects India's economy to grow at 6.8% in...

Mahindra Group Chairman Anand Mahindra urges Indian companies to increase capital investment to capitalize on growth opportunities in India and globally. He emphasizes the need for a shift in...

India's tyre industry is facing a severe shortage of natural rubber, which could disrupt production. The Automotive Tyre Manufacturers' Association (ATMA) is urging the government to address the...